|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation, amortization and impairment | |||||
| Share-based compensation | |||||
| Capital loss | |||||
| Amortization of issuance costs of Convertible debt | |||||
| Loss from extinguishment | |||||
| Other income | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (Increase) in accrued severance pay, net | |||||
| Decrease (Increase) in other assets, other receivables and prepaid expenses | |||||
| Decrease in accrued interest and amortization of premium on available-for sale marketable securities | |||||
| Decrease in operating lease right-of-use asset | |||||
| Decrease in operating leases liability | |||||
| Decrease (Increase) in trade receivables | |||||
| Decrease (Increase) in inventories | |||||
| Decrease in long-term deferred taxes, net | |||||
| Decrease in trade payables | |||||
| Increase (Decrease) in employees and payroll accruals | |||||
| Increase (Decrease) in deferred revenues | |||||
| Increase (Decrease) in other payables and accrued expenses | |||||
| Gain of foreign exchange on cash and cash equivalents | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Decrease (Increase) in restricted deposit | |||||
| Investment in short-term deposits | |||||
| Investment in short-term bank deposits | |||||
| Withdrawal in short-term bank deposits | |||||
| Purchase of property and equipment | |||||
| Investment in available-for sale marketable securities | |||||
| Proceeds from sales and maturity of available-for sale marketable securities | |||||
| Proceeds from redemption of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Total proceeds from sales and maturity of available-for sale marketable securities | |||||
| Acquisition | |||||
| Proceeds from sale of patent | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuance of share capital | |||||
| Proceeds from exercise of share options | |||||
| Issuance of convertible debt | |||||
| Redemption of convertible debt | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Supplementary cash flow information: | |||||
| Cash paid during the year for: | |||||
| Income Taxes Paid, Net | |||||
| Interest received | |||||
| Non-cash activity: | |||||
| ROU asset and lease liability decrease, due to lease termination | |||||
| Redemption of convertible debt | |||||
| Right-of-use assets obtained in the exchange for operating lease liabilities | |||||
Loading...